2.09 USD
↗ 0.07 (3.47%)AT CLOSE (11:59 AM EDT)
Compugen Ltd
CGENNASDAQ • USD
2.09
↗ 0.00 (0.00%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
2.09
↗ 0.00 (0.00%)
Market: CLOSED
Shares of Compugen Ltd (CGEN) are trading at $2.09. CGEN shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9 and a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Jun 26, 2026.
Open?$2.03
High?$2.10
Low?$2.01
Prev. Close?$2.02
Volume?293.5K
Avg. Volume?N/A
VWAP?$2.07
Bid / Ask
Bid?$1.77 × 100
Ask?$2.40 × 100
Spread?$0.63
Midpoint?$2.09
Valuation & Ratios
Market Cap?191.1M
Shares Out?N/A
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Themes
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?1
Momentum?50
Short Sent.?50
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.46Distress
Confidence?45%Low
Short InterestHigh
Short Interest?2.9M
Days to Cover?5.7
Avg Daily Volume502.6K
Settlement Date2026-06-15